Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-23

Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of Topically Applied TV-45070 (Ointment) in Participants With Primary Osteoarthritis (OA) Affecting a Single Knee [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of topically applied TV-45070 ointment in osteoarthritis of the knee; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TV-45070 (TV-45070)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Osteoarthritis of the Knee | Phase 2 | Status: COMPLETED | Results posted: 2018-10-23